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Confidentiality must be ensured even in the preparation and 
distribution of medications in detention settings. In this respect, the 
European Committee for the Prevention of Torture and Inhuman or 
Degrading Treatment or Punishment found during recent prison visits 
several instances where prison staff, and at times detainees, 
dispensed prescribed treatments and supervised their intake. Such a 
practice compromises medical confidentiality requirements and the 
establishment of a trusting doctor-patient relationship. To respect 
medical confidentiality and ensure safety and quality of care, the 
authors argue that only qualified healthcare personnel should 
prepare and distribute prescribed medications, all of which require 
specialized training. They call for robust research that examines the 
operational barriers and facilitators as well as the respect of human 
rights related to various approaches to medication preparation, 
distribution, and intake so that people in detention can access their 
treatment with safety, confidentiality, autonomy, and dignity.
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Background
The European Committee for the Prevention of Torture and 
Inhuman or Degrading Treatment or Punishment (CPT) pro-
vides a non-judicial preventive mechanism to protect persons 
deprived of liberty against torture and other forms of ill-treatment1. 
The CPT visits detention places in the 47 member states of 
the Council of Europe. The visits include the assessment of 
medical services in carceral settings to gain insights into the way 
individuals access healthcare prevention, treatment, and care. 
The access to healthcare services for individuals experiencing 
incarceration is essential as this priority population carries a high 
burden of physical and mental health conditions2–5. Operating 
such services in prison must be underpinned by the following 
guiding principles: timely access to competent medical staff 
who work independently from the criminal justice system6, 
equivalence of preventive and curative care services that are 
free-of-charge to patients (i.e., states bear all the healthcare 
costs), humanitarian assistance to individuals with increased 
vulnerabilities (e.g., mothers with children, adolescents), and 
patient’s right to informed consent and confidentiality7. Failing 
to respect these principles can result in situations falling within 
the scope of inhumane and degrading treatment. The objective 
of this article is to underscore the paramountcy of upholding 
confidentiality in the preparation and distribution of medication, as 
highlighted by recent CPT visits.
Examples of violations
There is a paucity of published peer-reviewed literature on 
this subject and our sources stem from published CPT reports. 
Once prescribed, medications require coordinated preparation 
and distribution for individuals to have timely access to their 
treatment. In Scotland, the CPT delegation found that medical 
and prison staff shared the task of distributing medication and 
supervising its intake8. In Greece, prison staff and detained 
individuals were acting as orderlies (i.e., they were trained in 
first aid and selected clinical tasks), who dispensed medication 
under the supervision of nurses and had access to patient medical 
records9. In Norway, it was the duty of the custodial officers 
to distribute prescribed medications despite the daily presence 
of a nurse10. In Estonia, nurses prepared the medication, and 
custodial staff ensured its distribution except for psychotropic 
treatment, which was delivered by nurses11. In Cyprus, several 
prison officers worked as medical orderlies who distributed 
medication and accompanied doctors on their rounds, with a 
few assigned to medical duty during the day or at night12. In the 
Netherlands, external pharmacies prepared the medication and 
custodial staff carried out its distribution. For prescribed opioids 
and psychiatric medication, prison officers also had to check 
that recipients swallowed them properly (patients reported 
that they had occasionally received the wrong medication, for 
example that of their neighbor, due to a lack of attention by the 
prison officer)13.
CPT rules and recommendations
Cooperation between healthcare professionals and prison 
authorities is necessary if it is deemed reasonable and respects 
the guiding principles mentioned above. However, in the given 
examples, the distribution of medication, including psychotropic 
substances and methadone, by prison officers or by incarcerated 
persons compromised the respect of medical confidentiality—the 
medication name and its dosage were visible. Such a practice 
could compromise medical confidentiality requirements and the 
establishment of a proper doctor-patient relationship.
According to the 1992 CPT report, there should be appropriate 
supervision of the pharmacy and the distribution of medicines. 
Further, the preparation of medicines should always be entrusted 
to qualified staff (pharmacist/nurse, etc.)7 In other words, to 
respect medical confidentiality and ensure safety and quality 
of care, individuals in prison and custodial staff should not be 
involved in performing healthcare tasks and only qualified 
healthcare personnel should prepare and distribute prescribed 
medications, all of which require specialized training.
We acknowledge the difficulty in following this recommenda-
tion, especially in smaller detention facilities, where health-
care professionals are not available 24h/7 when compared 
to larger and high security facilities. These facilities tend to 
have the most comprehensive healthcare services and staffing 
because the patient population is older and present for a longer 
period14. However, irrespective of the size of the detention 
centers, people experiencing incarceration use health services 
more often when compared with the community15. We also 
understand that ensuring access to medication while respect-
ing confidentiality, complying with prison security require-
ments, and accounting for fears of theft, trafficking, and 
misuse, especially of psychoactive medication16, needs a balanced 
operational approach.
Recommendations for best practice
The best-case scenario, one that respects medical confidentiality 
and quality of care while empowering patients in their auton-
omy, would comprise the following steps: as blister medication 
increases adherence to treatment17, prescribed medications are 
left in their blisters (for tablets) and packaged individually for 
each patient by healthcare staff (such as in the detention facilities 
of Geneva, Switzerland) or an automated pharmacy preparation 
system (such as in larger facilities in France); to avoid the 
confusion of roles between healthcare and prison staff18 and to 
respect patients’ right to confidentiality19, healthcare profession-
als—not prison officers or incarcerated individuals—distribute 
the medications either in-hand (as privately and confidentially 
as possible) or in individual lockable medication boxes that each 
user can independently access (such as at La Brenaz facility in 
Geneva); and when supervised intake is not medically indicated, 
patients should have the option of taking their treatment in the 
privacy of their cells.
However, based on the CPT experience, there are limited 
examples that adhere to this best-case scenario. Therefore, we 
call for robust operational research that examines the operational 
barriers and facilitators as well as the respect of human rights 
related to various approaches to medication preparation, distribu-
tion, and intake. Identifying and disseminating best practices that 
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are rights-based will allow people in detention to access their 
treatment with safety, confidentiality, autonomy, and dignity.
Data availability
No data are associated with this article.
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Overall, this is a very well written commentary with some important implications. I do think there 
could be a few additional considerations incorporated in order to broaden the applicability of the 
perspective and recommendations. For example, in some parts of the world (e.g. US) correctional 
facilities contract medical services to a third-party vendor. As such, there needs to be additional 
coordination between corrections-based staff and non-corrections based medical staff, especially 
with respect to facilitating medical appointments and medication receipt. With respect to the 
recommendations for best practice, while the best-case scenario the authors outline is one that all 
facilities should strive to achieve, it would be nice to see some gradation of compliance with this 
best-practice in order to make it a bit more practical and/or feasible. For example, if facilities do 
not have the resources, especially in terms of medical staff to adequately supervise medication, 
what can be done to mitigate concerns re breaches in confidentiality? It would be good to see 
recommendations for facilities across a “spectrum” of compliance such that those facilities in poor 
resourced settings do not feel as though they must undertake an all or nothing approach. Again, if 
facilities can take measured steps toward achieving the stated best-case scenario, they should be 
strongly encouraged to do so.
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